Application 1096
Hepatitis B DNA testing
Application No. | 1096 |
| Application Name | Hepatitis B DNA testing |
| Advisory Panel | Professor Syd Bell (Chair and MSAC member) Dr Debra Graves (MSAC member) Professor Peter Angus (co-opted member) Dr Geoff Higgins (co-opted member) Dr Katrina Watson (co-opted member) Mr Martyn Goddard (co-opted member) Ms Janney Wale (Consumers' Health Forum nominee) Ms Sharyn McGregor (Hepatitis C Section, Department of Health and Ageing) |
| Date Received by MSAC Secretariat | 8 March 2005 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 9 March 2007 meeting. MSAC finds there is sufficient evidence of the safety, effectiveness and cost effectiveness of hepatitis B assay in the pre-treatment and in the monitoring of patients with chronic hepatitis B. MSAC recommends that public funding be provided for the use of hepatitis B assay in patients with chronic hepatitis B. MSAC further recommends that the number of hepatitis B assays for pre-treatment assessment or for the monitoring of patients with chronic hepatitis B who are not on antiviral therapy be restricted to one assay in a twelve month period and for patients on antiviral therapy the number of assays be restricted to four assays in a twelve month period. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing on 4 June 2007 |
| Stage 5 - Implementation | Implemented |
